Timothy R Morgan

Title(s)Professor In Residence, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(562) 826-5756
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
    NIH R01AA018389Sep 25, 2018 - Jun 30, 2021
    Role: Principal Investigator
    A prospective, randomized, clinical trial to evaluate two novel therapies, mycoph
    NIH U01AA021886Sep 20, 2013 - Aug 31, 2020
    Role: Principal Investigator
    Southern California Alcoholic Hepatitis Consortium Administrative Core
    NIH U01AA021884Sep 20, 2013 - Aug 31, 2018
    Role: Principal Investigator
    Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
    NIH U01AA018389Sep 20, 2011 - Jun 30, 2020
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi. Hepatology. 2024 Apr 01. Tapper EB, Warner MA, Shah RP, Emamaullee J, Dunbar NM, Sholzberg M, Poston JN, Soto RJ, Sarwar A, Pillai A, Reyner K, Mehta S, Ghabril M, Morgan TR, Caldwell S. PMID: 38557474.
      View in: PubMed   Mentions:    Fields:    
    2. Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2024 Mar 27. Brahmania M, Kuo A, Tapper EB, Volk M, Vittorio JM, Ghabril M, Morgan T, Kanwal F, Parikh ND, Martin P, Mehta S, Winder GS, Im GY, Goldberg D, Lai JC, Duarte-Rojo A, Paredes AH, Patel AA, Sahota A, McElroy LM, Thomas C, Wall AE, Malinis M, Aslam S, Simonetto DA, Ufere NN, Ramakrishnan S, Flynn MM, Ibrahim Y, Asrani SK, Serper M. PMID: 38536021.
      View in: PubMed   Mentions:    Fields:    
    3. Steroid responsiveness in alcohol-associated hepatitis is linked to glucocorticoid metabolism, mitochondrial repair, and heat shock proteins. Hepatol Commun. 2024 Mar 01; 8(3). Hardesty J, Hawthorne M, Day L, Warner J, Warner D, Gritsenko M, Asghar A, Stolz A, Morgan T, McClain C, Jacobs J, Kirpich IA. PMID: 38437061; PMCID: PMC10914234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning. PLOS Digit Health. 2024 Feb; 3(2):e0000447. Listopad S, Magnan C, Day LZ, Asghar A, Stolz A, Tayek JA, Liu ZX, Jacobs JM, Morgan TR, Norden-Krichmar TM. PMID: 38335183; PMCID: PMC10857706.
      View in: PubMed   Mentions:
    5. Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era. Clin Infect Dis. 2024 Jan 27. Varley CD, Lowy E, Cartwright EJ, Morgan TR, Ross DB, Rozenberg-Ben-Dror K, Beste LA, Maier MM. PMID: 38279939.
      View in: PubMed   Mentions:    Fields:    
    6. Undiagnosed Cirrhosis and Hepatic Encephalopathy in a National Cohort of Veterans With Dementia. JAMA Netw Open. 2024 Jan 02; 7(1):e2353965. Bajaj JS, Silvey SG, Rogal S, O'Leary JG, Patton H, Morgan TR, Kanagalingam G, Gentili A, Godschalk M, Patel N. PMID: 38294815; PMCID: PMC10831576.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Single-cell transcriptomics of peripheral blood mononuclear cells indicates impaired immune and inflammatory responses in alcohol-associated hepatitis. Hum Immunol. 2024 Jan; 85(1):110735. Liu X, Liu ZX, Morgan TR, Norden-Krichmar TM. PMID: 38040543.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Comparing the CFIR-ERIC matching tool recommendations to real-world strategy effectiveness data: a mixed-methods study in the Veterans Health Administration. Implement Sci. 2023 10 12; 18(1):49. Yakovchenko V, Lamorte C, Chinman MJ, Goodrich DE, Gibson S, Park A, Bajaj JS, McCurdy H, Morgan TR, Rogal SS. PMID: 37828539; PMCID: PMC10571268.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Reply. Gastroenterology. 2023 Dec; 165(6):1587-1588. Hunt CM, Lee TH, Morgan TR, Campbell S. PMID: 37783280.
      View in: PubMed   Mentions:    Fields:    
    10. Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project. Clin Gastroenterol Hepatol. 2024 02; 22(2):324-338. Rogal SS, Taddei TH, Monto A, Yakovchenko V, Patton H, Merante M, Spoutz P, Chia L, Yudkevich J, Aytaman A, Rabiee A, John BV, Blechacz B, Cai CX, Gilles H, Shah AS, McCurdy H, Puri P, Jou J, Mazhar K, Dominitz JA, Anwar J, Morgan TR, Ioannou GN. PMID: 37460005; PMCID: PMC10788380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Dec 01; 78(6):1966-1986. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group. PMID: 37363821; PMCID: PMC10653297.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    12. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023 12; 79(6):1542-1556. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group. PMID: 37364790.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    13. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024 Jan-Feb; 29(1):101133. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Narro GEC, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gómez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group. PMID: 37364816.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    14. All perspectives need to be accounted for when determining the effectiveness of therapies for alcohol use disorder. Hepatol Commun. 2023 06 01; 7(6). Rogal SS, Chaudhari RB, Morgan TR, Bajaj JS. PMID: 37255351; PMCID: PMC10234461.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. User experience of a hepatitis c population management dashboard in the Department of Veterans Affairs. PLoS One. 2023; 18(5):e0285044. Yakovchenko V, Jacob DA, Rogal SS, Morgan TR, Rozenberg-Ben-Dror K. PMID: 37130107; PMCID: PMC10153746.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. One ALT Is Not Like the Other. Gastroenterology. 2023 Aug; 165(2):320-323. Hunt CM, Lee TH, Morgan TR, Campbell S. PMID: 37094663.
      View in: PubMed   Mentions: 1     Fields:    
    17. Refining Expert Recommendations for Implementing Change (ERIC) strategy surveys using cognitive interviews with frontline providers. Implement Sci Commun. 2023 Apr 21; 4(1):42. Yakovchenko V, Chinman MJ, Lamorte C, Powell BJ, Waltz TJ, Merante M, Gibson S, Neely B, Morgan TR, Rogal SS. PMID: 37085937; PMCID: PMC10122282.
      View in: PubMed   Mentions: 1  
    18. Early paracentesis is associated with better prognosis compared with late or no-paracentesis in hospitalized veterans with cirrhosis and ascites. Liver Transpl. 2023 09 01; 29(9):919-927. Patel N, Silvey S, O'Leary JG, Morgan T, Patton H, Rogal SS, Bajaj JS. PMID: 36971257; PMCID: PMC10523869.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. The road to pandemic recovery: Tracking COVID-19's impact on cirrhosis care and outcomes among 111,558 Veterans. Hepatology. 2023 06 01; 77(6):2016-2029. Adejumo AC, Yakovchenko V, Morgan TR, Spoutz P, Chia L, Bajaj JS, Chang MF, Dominitz JA, Rogal SS. PMID: 36705024.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    20. Dementia Frequently Coexists With Hepatic Encephalopathy but Not Other Cirrhosis Complications in US Veterans. Am J Gastroenterol. 2023 03 01; 118(3):475-480. Adejumo A, Noll A, Rogal SS, Yakovchenko V, Chia L, Spoutz P, Morgan TR, Bajaj JS. PMID: 36649134.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Getting to implementation: Adaptation of an implementation playbook. Front Public Health. 2022; 10:980958. Yakovchenko V, Rogal SS, Goodrich DE, Lamorte C, Neely B, Merante M, Gibson S, Scott D, McCurdy H, Nobbe A, Morgan TR, Chinman MJ. PMID: 36684876; PMCID: PMC9853037.
      View in: PubMed   Mentions:    Fields:    
    22. Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration. Hepatology. 2023 06 01; 77(6):2030-2040. Badal BD, Silvey S, Dragilev L, O'Leary JG, Morgan TR, Cheung R, Patel A, Rogal S, Patton H, Nobbe A, Jakab SS, Liu J, Patel N, Bajaj JS. PMID: 36645215.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    23. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank. Alcohol Clin Exp Res. 2022 12; 46(12):2245-2257. Whitfield JB, Seth D, Morgan TR, GenomALC Consortium. PMID: 36317527; PMCID: PMC10098765.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated Hepatitis. Am J Pathol. 2022 12; 192(12):1658-1669. Argemi J, Kedia K, Gritsenko MA, Clemente-Sanchez A, Asghar A, Herranz JM, Liu ZX, Atkinson SR, Smith RD, Norden-Krichmar TM, Day LZ, Stolz A, Tayek JA, Bataller R, Morgan TR, Jacobs JM, Southern California Alcoholic Hepatitis Consortium and the InTeam Consortium. PMID: 36243044; PMCID: PMC9765311.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis. EClinicalMedicine. 2022 Dec; 54:101689. Tayek JA, Stolz AA, Nguyen DV, Fleischman MW, Donovan JA, Alcorn JM, Chao DC, Asghar A, Morgan TR, Southern California Alcoholic Hepatitis (SCAH) Consortium. PMID: 36267499; PMCID: PMC9576807.
      View in: PubMed   Mentions: 4  
    26. Reply to: "External validation of a genetic risk score that predicts development of alcohol-related cirrhosis". J Hepatol. 2022 12; 77(6):1721-1722. Whitfield JB, Morgan TR, Seth D. PMID: 36055430.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples. JHEP Rep. 2022 Oct; 4(10):100560. Listopad S, Magnan C, Asghar A, Stolz A, Tayek JA, Liu ZX, Morgan TR, Norden-Krichmar TM. PMID: 36119721; PMCID: PMC9472076.
      View in: PubMed   Mentions: 2  
    28. Improving quality of hepatitis B care in the Veteran's Health Administration. Clin Liver Dis (Hoboken). 2022 Jun; 19(6):213-218. Rozenberg-Ben-Dror K, Maier MM, Beste L, Lowy E, Chartier M, Ross D, Morgan TR. PMID: 35795619; PMCID: PMC9248930.
      View in: PubMed   Mentions: 1  
    29. Robust Hepatitis A Vaccination Response Within the United States Veterans Health Administration in the Wake of State Outbreaks. Am J Public Health. 2022 07; 112(7):990-994. Moon AM, Borgerding JA, Hauser RG, Lowy E, Chartier M, Maier MM, Morgan T, Ruege A, Weber J, Beste LA. PMID: 35617651; PMCID: PMC9222460.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    30. Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis. Am J Pathol. 2022 07; 192(7):1066-1082. Hardesty J, Day L, Warner J, Warner D, Gritsenko M, Asghar A, Stolz A, Morgan T, McClain C, Jacobs J, Kirpich I. PMID: 35490715; PMCID: PMC9253914.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set. J Viral Hepat. 2022 06; 29(6):474-486. Morgan JR, Marsh E, Savinkina A, Shilton S, Shadaker S, Tsertsvadze T, Kamkamidze G, Alkhazashvili M, Morgan T, Belperio P, Backus L, Doss W, Esmat G, Hassany M, Elsharkawy A, Elakel W, Mehrez M, Foster GR, Wose Kinge C, Chew KW, Chasela CS, Sanne IM, Thanung YM, Loarec A, Aslam K, Balkan S, Easterbrook PJ, Linas BP. PMID: 35278339; PMCID: PMC9248016.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    32. Core implementation strategies for improving cirrhosis care in the Veterans Health Administration. Hepatology. 2022 08; 76(2):404-417. Yakovchenko V, Morgan TR, Miech EJ, Neely B, Lamorte C, Gibson S, Beste LA, McCurdy H, Scott D, Gonzalez RI, Park AM, Powell BJ, Bajaj JS, Dominitz JA, Chartier M, Ross DB, Chinman MJ, Rogal SS. PMID: 35124820; PMCID: PMC9288973.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275-282]. J Hepatol. 2022 May; 76(5):1244-1245. Whitfield JB, Schwantes-An TH, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet JM, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D, GenomALC Consortium. PMID: 35287983.
      View in: PubMed   Mentions:    Fields:    
    34. Detecting High-Resolution Intramural Vascular Wall Strain Signals Using DICOM Data. ASAIO J. 2022 03 01; 68(3):440-445. Weitzel WF, Thelen BJ, Rajaram N, Gao J, Hamilton J, Morgan T, Zheng Y, Funes-Lora MA, Krishnamurthy VN, Osborne N, Henke P, Bishop B, Yessayan L, Shih AJ. PMID: 34049311.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Semiautomated Software to Improve Stability and Reduce Operator-Induced Variation in Vascular Ultrasound Speckle Tracking. J Ultrasound Med. 2022 Nov; 41(11):2755-2766. Rajaram N, Thelen BJ, Hamilton JD, Zheng Y, Morgan T, Funes-Lora MA, Yessayan L, Shih AJ, Henke P, Osborne N, Bishop B, Krishnamurthy VN, Weitzel WF. PMID: 35170801.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 07; 76(1):251-274. Serper M, Parikh ND, Thiele G, Ovchinsky N, Mehta S, Kuo A, Ho C, Kanwal F, Volk M, Asrani SK, Ghabril MS, Lake JR, Merriman RB, Morgan TR, Tapper EB. PMID: 34990516; PMCID: PMC10648308.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    37. Ultrasound Measurement of Vascular Distensibility Based on Edge Detection and Speckle Tracking Using Ultrasound DICOM Data. ASAIO J. 2022 01 01; 68(1):112-121. Funes-Lora MA, Thelen BJ, Shih AJ, Hamilton J, Rajaram N, Lyu J, Zheng Y, Morgan T, Weitzel WF. PMID: 34380948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 05; 75(5):1289-1299. Asrani SK, Ghabril MS, Kuo A, Merriman RB, Morgan T, Parikh ND, Ovchinsky N, Kanwal F, Volk ML, Ho C, Serper M, Mehta S, Agopian V, Cabrera R, Chernyak V, El-Serag HB, Heimbach J, Ioannou GN, Kaplan D, Marrero J, Mehta N, Singal A, Salem R, Taddei T, Walling AM, Tapper EB. PMID: 34778999.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. Reply. Hepatology. 2022 04; 75(4):1055-1056. Aronsohn AI, Bhattacharya D, Morgan TR, Wyles DL, Chung RT, McQuillen DP, AASLD-IDSA HCV Guidance. PMID: 34859470.
      View in: PubMed   Mentions: 1     Fields:    
    40. Mapping the road to elimination: a 5-year evaluation of implementation strategies associated with hepatitis C treatment in the veterans health administration. BMC Health Serv Res. 2021 Dec 18; 21(1):1348. Yakovchenko V, Morgan TR, Chinman MJ, Powell BJ, Gonzalez R, Park A, Malone PS, Chartier M, Ross D, Rogal SS. PMID: 34922538; PMCID: PMC8684191.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    41. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatol. 2022 02; 76(2):275-282. Whitfield JB, Schwantes-An TH, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet JM, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D, GenomALC Consortium. PMID: 34656649; PMCID: PMC8803006.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    42. Development and Implementation of Multidisciplinary Liver Tumor Boards in the Veterans Affairs Health Care System: A 10-Year Experience. Cancers (Basel). 2021 Sep 28; 13(19). Rabiee A, Taddei T, Aytaman A, Rogal SS, Kaplan DE, Morgan TR. PMID: 34638333; PMCID: PMC8508370.
      View in: PubMed   Mentions: 2  
    43. HCV Elimination in the US Department of Veterans Affairs. Clin Liver Dis (Hoboken). 2021 Jul; 18(1):1-6. Gonzalez R, Park A, Yakovchenko V, Rogal S, Chartier M, Morgan TR, Ross D. PMID: 34484696; PMCID: PMC8405054.
      View in: PubMed   Mentions: 5  
    44. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. Am J Gastroenterol. 2021 07 01; 116(7):1406-1413. Rogal S, Youk A, Agbalajobi O, Zhang H, Gellad W, Fine MJ, Belperio P, Morgan T, Good CB, Kraemer K. PMID: 33811202; PMCID: PMC8819871.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Impact of underground storm drain systems on larval ecology of Culex and Aedes species in urban environments of Southern California. Sci Rep. 2021 06 16; 11(1):12667. Wang X, Zhou G, Zhong D, Li Y, Octaviani S, Shin AT, Morgan T, Nguyen K, Bastear J, Doyle M, Cummings RF, Yan G. PMID: 34135430; PMCID: PMC8209202.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsPHPublic Health
    46. Strategies to Improve Delivery of Cirrhosis Care. Curr Treat Options Gastroenterol. 2021; 19(2):369-379. Moghe A, Yakovchenko V, Morgan T, McCurdy H, Scott D, Rozenberg-Ben-Dror K, Rogal S. PMID: 34054289; PMCID: PMC8142883.
      View in: PubMed   Mentions: 2  
    47. The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance. Cancers (Basel). 2021 May 07; 13(9). Rogal SS, Yakovchenko V, Gonzalez R, Park A, Beste LA, Rozenberg-Ben-Dror K, Bajaj JS, Scott D, McCurdy H, Comstock E, Sidorovic M, Gibson S, Lamorte C, Nobbe A, Chartier M, Ross D, Dominitz JA, Morgan TR. PMID: 34067177; PMCID: PMC8125814.
      View in: PubMed   Mentions: 6  
    48. Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors. Hepatology. 2021 05; 73(5):1920-1931. Schwantes-An TH, Darlay R, Mathurin P, Masson S, Liangpunsakul S, Mueller S, Aithal GP, Eyer F, Gleeson D, Thompson A, Muellhaupt B, Stickel F, Soyka M, Goldman D, Liang T, Lumeng L, Pirmohamed M, Nalpas B, Jacquet JM, Moirand R, Nahon P, Naveau S, Perney P, Botwin G, Haber PS, Seitz HK, Day CP, Foroud TM, Daly AK, Cordell HJ, Whitfield JB, Morgan TR, Seth D, GenomALC Consortium. PMID: 32853455.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    49. In Reply. Arch Pathol Lab Med. 2021 02 01; 145(2):129b-130. Beste LA, Icardi M, Hunt CM, Gylys-Colwell I, Lowy E, Taylor L, Morgan TR, Chang MF, Maier MM, Cheung R. PMID: 33501499.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Use of Mobile Technology Paired with Heart Rate Monitor to Remotely Quantify Behavioral Health Markers among Military Reservists and First Responders. Mil Med. 2021 01 25; 186(Suppl 1):17-24. Davila MI, Kizakevich PN, Eckhoff R, Morgan J, Meleth S, Ramirez D, Morgan T, Strange LB, Lane M, Weimer B, Lewis A, Lewis GF, Hourani LI. PMID: 33499533.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. Am J Gastroenterol. 2021 01 01; 116(1):106-115. Whitfield JB, Masson S, Liangpunsakul S, Mueller S, Aithal GP, Eyer F, Gleeson D, Thompson A, Stickel F, Soyka M, Muellhaupt B, Daly AK, Cordell HJ, Foroud T, Lumeng L, Pirmohamed M, Nalpas B, Jacquet JM, Moirand R, Nahon P, Naveau S, Perney P, Haber PS, Seitz HK, Day CP, Mathurin P, Morgan TR, Seth D, GenomALC Consortium. PMID: 32868629.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    52. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis. Gastroenterology. 2021 04; 160(5):1725-1740.e2. Massey V, Parrish A, Argemi J, Moreno M, Mello A, García-Rocha M, Altamirano J, Odena G, Dubuquoy L, Louvet A, Martinez C, Adrover A, Affò S, Morales-Ibanez O, Sancho-Bru P, Millán C, Alvarado-Tapias E, Morales-Arraez D, Caballería J, Mann J, Cao S, Sun Z, Shah V, Cameron A, Mathurin P, Snider N, Villanueva C, Morgan TR, Guinovart J, Vadigepalli R, Bataller R. PMID: 33309778; PMCID: PMC8613537.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    53. Getting to implementation: a protocol for a Hybrid III stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for Veterans. Implement Sci. 2020 10 21; 15(1):92. Rogal SS, Yakovchenko V, Morgan T, Bajaj JS, Gonzalez R, Park A, Beste L, Miech EJ, Lamorte C, Neely B, Gibson S, Malone PS, Chartier M, Taddei T, Garcia-Tsao G, Powell BJ, Dominitz JA, Ross D, Chinman MJ. PMID: 33087156; PMCID: PMC7579930.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. Characterizing patient-reported outcomes in veterans with cirrhosis. PLoS One. 2020; 15(9):e0238712. Rogal SS, Yakovchenko V, Gonzalez R, Park A, Lamorte C, Gibson SP, Chartier M, Ross D, Comstock E, Bajaj JS, Morgan TR. PMID: 32915828; PMCID: PMC7485762.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. A comparison of psychological resilience and related factors in Chinese firstborn and only children. Asian J Psychiatr. 2020 Oct; 53:102360. Morgan T, Yang S, Liu B, Cao Y. PMID: 32871400.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Electronic-Cigarette Vehicles and Flavoring Affect Lung Function and Immune Responses in a Murine Model. Int J Mol Sci. 2020 Aug 21; 21(17). Szafran BN, Pinkston R, Perveen Z, Ross MK, Morgan T, Paulsen DB, Penn AL, Kaplan BLF, Noël A. PMID: 32825651; PMCID: PMC7504509.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    57. Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis. Hepatology. 2020 06; 71(6):2080-2092. Rogal S, Youk A, Zhang H, Gellad WF, Fine MJ, Good CB, Chartier M, DiMartini A, Morgan T, Bataller R, Kraemer KL. PMID: 31758811; PMCID: PMC8032461.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    58. Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative Methods. Med Care. 2020 05; 58(5):e31-e38. Yakovchenko V, Miech EJ, Chinman MJ, Chartier M, Gonzalez R, Kirchner JE, Morgan TR, Park A, Powell BJ, Proctor EK, Ross D, Waltz TJ, Rogal SS. PMID: 32187105; PMCID: PMC7161717.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    59. Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease. Alcohol Clin Exp Res. 2020 05; 44(5):1061-1074. Marrero I, Maricic I, Morgan TR, Stolz AA, Schnabl B, Liu ZX, Tsukamoto H, Kumar V. PMID: 32154597; PMCID: PMC7211132.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    60. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 02; 71(2):686-721. Ghany MG, Morgan TR, AASLD-IDSA Hepatitis C Guidance Panel. PMID: 31816111; PMCID: PMC9710295.
      View in: PubMed   Mentions: 418     Fields:    Translation:Humans
    61. A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index. Cancer Prev Res (Phila). 2020 02; 13(2):203-212. Zell JA, McLaren CE, Morgan TR, Lawson MJ, Rezk S, Albers CG, Chen WP, Carmichael JC, Chung J, Richmond E, Rodriguez LM, Szabo E, Ford LG, Pollak MN, Meyskens FL. PMID: 31818851; PMCID: PMC8025666.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    62. Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012-2017. Arch Pathol Lab Med. 2020 06; 144(6):748-754. Beste LA, Icardi M, Hunt CM, Gylys-Colwell I, Lowy E, Taylor L, Morgan TR, Chang MF, Maier MM, Cheung R. PMID: 31697169.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration. Dig Dis Sci. 2019 12; 64(12):3471-3479. Dunn SH, Rogal SS, Maier MM, Chartier M, Morgan TR, Beste LA. PMID: 31432344.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. Longitudinal assessment of the association between implementation strategy use and the uptake of hepatitis C treatment: Year 2. Implement Sci. 2019 04 08; 14(1):36. Rogal SS, Yakovchenko V, Waltz TJ, Powell BJ, Gonzalez R, Park A, Chartier M, Ross D, Morgan TR, Kirchner JE, Proctor EK, Chinman MJ. PMID: 30961615; PMCID: PMC6454775.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    65. The Veterans Affairs Hepatitis C Treatment Considerations. Am J Gastroenterol. 2019 02; 114(2):185-188. Yee HS, Burton MJ, Belperio PS, Morgan TR. PMID: 30315291.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    66. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis? Clin Liver Dis. 2019 02; 23(1):157-165. Sundaram V, Morgan TR. PMID: 30454829.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals. J Virus Erad. 2019 Jan 01; 5(1):60-66. Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, Sypsa V, Morgan T, Gamkrelidze A, Mukabatsinda C, Deuffic-Burban S, Ninburg M, Feld J, Hellard M, Ward J. PMID: 30800429; PMCID: PMC6362901.
      View in: PubMed   Mentions: 27  
    68. Characteristics of Opioid Prescriptions to Veterans With Cirrhosis. Clin Gastroenterol Hepatol. 2019 05; 17(6):1165-1174.e3. Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, Chinman M, Morgan T, Gellad WF. PMID: 30342261; PMCID: PMC8108399.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    69. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol. 2018 Aug 24; 17(5):759-768. Wu T, Morgan TR, Klein AS, Volk ML, Saab S, Sundaram V. PMID: 30145578.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. Screening and Treating Hepatitis C in the VA: Achieving Excellence Using Lean and System Redesign. Fed Pract. 2018 Jul; 35(7):24-29. Park A, Gonzalez R, Chartier M, Rogal S, Yakovchenko V, Ross D, Morgan TR. PMID: 30766371; PMCID: PMC6368013.
      View in: PubMed   Mentions: 15  
    71. Is Granulocyte Colony Stimulating Factor a New Treatment for Alcoholic Hepatitis? Clin Gastroenterol Hepatol. 2018 10; 16(10):1564-1565. Morgan TR. PMID: 29913276.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success. Infect Dis Clin North Am. 2018 06; 32(2):281-292. Belperio PS, Chartier M, Gonzalez RI, Park AM, Ross DB, Morgan TR, Backus LI. PMID: 29778256.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    73. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials. Gastroenterology. 2018 08; 155(2):458-468.e8. Louvet A, Thursz MR, Kim DJ, Labreuche J, Atkinson SR, Sidhu SS, O'Grady JG, Akriviadis E, Sinakos E, Carithers RL, Ramond MJ, Maddrey WC, Morgan TR, Duhamel A, Mathurin P. PMID: 29738698.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    74. Hepatitis A Virus Prevention and Vaccination Within and Outside the Veterans Health Administration in Light of Recent Outbreaks. Fed Pract. 2018 Mar; 35(Suppl 2):S32-S37. Moon AM, Lowy E, Maier MM, Chartier M, Morgan TR, Hoffman-Högg L, Beste LA. PMID: 30766392; PMCID: PMC6375401.
      View in: PubMed   Mentions: 3  
    75. Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration. Fed Pract. 2018 Mar; 35(Suppl 2):S49-S53. Chartier M, Maier MM, Morgan TR, Lowy E, Hoffman-Högg L, Ross D, Beste LA. PMID: 30766394; PMCID: PMC6375403.
      View in: PubMed   Mentions: 2  
    76. Extracorporeal liver assist device for alcoholic hepatitis: A potential silver lining? Liver Transpl. 2018 03; 24(3):330-332. Morgan T. PMID: 29365343.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology. 2018 05; 67(5):1737-1753. Khanova E, Wu R, Wang W, Yan R, Chen Y, French SW, Llorente C, Pan SQ, Yang Q, Li Y, Lazaro R, Ansong C, Smith RD, Bataller R, Morgan T, Schnabl B, Tsukamoto H. PMID: 29108122; PMCID: PMC5906140.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    78. Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins. Exp Mol Pathol. 2018 04; 104(2):125-129. Lu JG, Nguyen L, Samadzadeh S, Masouminia M, Mendoza A, Sweeney O, Tillman B, Afifyan N, Morgan T, French BA, French SW. PMID: 29425759; PMCID: PMC5891376.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    79. Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis. Exp Mol Pathol. 2018 02; 104(1):45-49. Nguyen L, Masouminia M, Mendoza A, Samadzadeh S, Tillman B, Morgan T, French B, French S. PMID: 29307797; PMCID: PMC5800980.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    80. Treatment of Alcoholic Liver Disease. Gastroenterol Hepatol (N Y). 2017 Jul; 13(7):425-427. Morgan TR. PMID: 28867971; PMCID: PMC5572973.
      View in: PubMed   Mentions: 3  
    81. Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotype. Am J Med Genet A. 2017 Jul; 173(7):1739-1746. Wade EM, Jenkins ZA, Daniel PB, Morgan T, Addor MC, Adés LC, Bertola D, Bohring A, Carter E, Cho TJ, de Geus CM, Duba HC, Fletcher E, Hadzsiev K, Hennekam RCM, Kim CA, Krakow D, Morava E, Neuhann T, Sillence D, Superti-Furga A, Veenstra-Knol HE, Wieczorek D, Wilson LC, Markie DM, Robertson SP. PMID: 28498505.
      View in: PubMed   Mentions: 12     Fields:    
    82. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample. Implement Sci. 2017 05 11; 12(1):60. Rogal SS, Yakovchenko V, Waltz TJ, Powell BJ, Kirchner JE, Proctor EK, Gonzalez R, Park A, Ross D, Morgan TR, Chartier M, Chinman MJ. PMID: 28494811; PMCID: PMC5425997.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    83. Race or genetic makeup for hepatitis C virus treatment decisions? Hepatology. 2017 06; 65(6):2124-2125. O'Brien TR, Kottilil S, Feld JJ, Morgan TR, Pfeiffer RM. PMID: 28100007; PMCID: PMC5444941.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    84. Trajectories of response to acupuncture for menopausal vasomotor symptoms: the Acupuncture in Menopause study. Menopause. 2017 02; 24(2):171-179. Avis NE, Coeytaux RR, Levine B, Isom S, Morgan T. PMID: 27676631; PMCID: PMC5266651.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    85. Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials. PLoS One. 2016; 11(11):e0166036. Loftfield E, O'Brien TR, Pfeiffer RM, Howell CD, Horst R, Prokunina-Olsson L, Weinstein SJ, Albanes D, Morgan TR, Freedman ND. PMID: 27832143; PMCID: PMC5104464.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    86. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection. Ann Hepatol. 2016 Nov-Dec 2016; 15(6):834-845. Rodriguez-Torres M, Lawitz E, Yangco B, Jeffers L, Han SH, Thuluvath PJ, Rustgi V, Harrison S, Ghalib R, Vierling JM, Luketic V, Zamor PJ, Ravendhran N, Morgan TR, Pearlman B, O'Brien C, Khallafi H, Pyrsopoulos N, Kong G, McPhee F, Yin PD, Hughes E, Treitel M. PMID: 27740516.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    87. Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia. Am J Hum Genet. 2016 08 04; 99(2):392-406. Wade EM, Daniel PB, Jenkins ZA, McInerney-Leo A, Leo P, Morgan T, Addor MC, Adès LC, Bertola D, Bohring A, Carter E, Cho TJ, Duba HC, Fletcher E, Kim CA, Krakow D, Morava E, Neuhann T, Superti-Furga A, Veenstra-Knol I, Wieczorek D, Wilson LC, Hennekam RC, Sutherland-Smith AJ, Strom TM, Wilkie AO, Brown MA, Duncan EL, Markie DM, Robertson SP. PMID: 27426733; PMCID: PMC4974064.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    88. Acupuncture in Menopause (AIM) study: a pragmatic, randomized controlled trial. Menopause. 2016 06; 23(6):626-37. Avis NE, Coeytaux RR, Isom S, Prevette K, Morgan T. PMID: 27023860; PMCID: PMC4874921.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    89. Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities. Clin Gastroenterol Hepatol. 2017 02; 15(2):282-288. Ho SB, Monto A, Peyton A, Kaplan DE, Byrne S, Moon S, Copans A, Rossaro L, Roy A, Le H, Dvory-Sobol H, Zhu Y, Brainard DM, Guyer W, Shaikh O, Fuchs M, Morgan TR, VALOR study team. PMID: 27237429.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    90. Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders. Dig Dis Sci. 2016 06; 61(6):1744-56. Cozen ML, Ryan JC, Shen H, Cheung R, Kaplan DE, Pocha C, Brau N, Aytaman A, Schmidt WN, Pedrosa M, Anand BS, Chang KM, Morgan T, Monto A. PMID: 27059981; PMCID: PMC5308124.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    91. Treatment of Severe Alcoholic Hepatitis. Gastroenterology. 2016 Jun; 150(8):1823-34. Thursz M, Morgan TR. PMID: 26948886; PMCID: PMC5828019.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    92. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016 Apr; 150(4):785-90. Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G, NIAAA Alcoholic Hepatitis Consortia. PMID: 26921783; PMCID: PMC5287362.
      View in: PubMed   Mentions: 172     Fields:    Translation:Humans
    93. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2016 Jan 05; 315(1):36-46. Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, Eggebeen J, Nicklas BJ. PMID: 26746456; PMCID: PMC4787295.
      View in: PubMed   Mentions: 267     Fields:    Translation:Humans
    94. Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial. Ann Intern Med. 2015 Dec 01; 163(11):818-26. Everson GT, Towner WJ, Davis MN, Wyles DL, Nahass RG, Thuluvath PJ, Etzkorn K, Hinestrosa F, Tong M, Rabinovitz M, McNally J, Brainard DM, Han L, Doehle B, McHutchison JG, Morgan T, Chung RT, Tran TT. PMID: 26551051.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    95. Predictors of Early Discontinuation of Pegylated Interferon for Reasons Other Than Lack of Efficacy in United States Veterans With Chronic Hepatitis C. Gastroenterol Nurs. 2015 Nov-Dec; 38(6):417-28. LaFleur J, Hoop R, Korner E, DuVall S, Morgan T, Pandya P, Han J, Knippenberg K, Nelson RE. PMID: 26626031.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med. 2015 Aug 20; 373(8):714-25. Wyles DL, Ruane PJ, Sulkowski MS, Dieterich D, Luetkemeyer A, Morgan TR, Sherman KE, Dretler R, Fishbein D, Gathe JC, Henn S, Hinestrosa F, Huynh C, McDonald C, Mills A, Overton ET, Ramgopal M, Rashbaum B, Ray G, Scarsella A, Yozviak J, McPhee F, Liu Z, Hughes E, Yin PD, Noviello S, Ackerman P, ALLY-2 Investigators. PMID: 26196502.
      View in: PubMed   Mentions: 151     Fields:    Translation:HumansCells
    97. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol. 2015 Nov; 63(5):1103-10. O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L. PMID: 26186989; PMCID: PMC4615534.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    98. A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prev Res (Phila). 2015 Sep; 8(9):864-72. Morgan TR, Osann K, Bottiglieri T, Pimstone N, Hoefs JC, Hu KQ, Hassanein T, Boyer TD, Kong L, Chen WP, Richmond E, Gonzalez R, Rodriguez LM, Meyskens FL. PMID: 26130251; PMCID: PMC4560676.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    99. Brief report: genetics of alcoholic cirrhosis-GenomALC multinational study. Alcohol Clin Exp Res. 2015 May; 39(5):836-42. Whitfield JB, Rahman K, Haber PS, Day CP, Masson S, Daly AK, Cordell HJ, Mueller S, Seitz HK, Liangpunsakul S, Westerhold C, Liang T, Lumeng L, Foroud T, Nalpas B, Mathurin P, Stickel F, Soyka M, Botwin GJ, Morgan TR, Seth D, GenomALC Consortium. PMID: 25872595; PMCID: PMC4398999.
      View in: PubMed   Mentions: 12     Fields:    
    100. Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis. Gastroenterology. 2015 Aug; 149(2):398-406.e8; quiz e16-7. Louvet A, Labreuche J, Artru F, Boursier J, Kim DJ, O'Grady J, Trépo E, Nahon P, Ganne-Carrié N, Naveau S, Diaz E, Gustot T, Lassailly G, Cannesson-Leroy A, Canva-Delcambre V, Dharancy S, Park SH, Moreno C, Morgan TR, Duhamel A, Mathurin P. PMID: 25935634.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    101. A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum. Cancer Prev Res (Phila). 2015 Mar; 8(3):222-30. Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen WP, Mo A, Tucker C, Bhattacharya A, Huang Z, Arcilla M, Wong V, Chung J, Gonzalez R, Rodriguez LM, Szabo E, Rosenberg DW, Lipkin SM. PMID: 25604134; PMCID: PMC4355051.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    102. Quality of life and factors predictive of burden among primary caregivers of chronic liver disease patients. Ann Gastroenterol. 2015 Jan-Mar; 28(1):124-129. Nguyen DL, Chao D, Ma G, Morgan T. PMID: 25608915; PMCID: PMC4289985.
      View in: PubMed   Mentions: 25  
    103. Corticosteroids can be used to treat alcoholic hepatitis after a recent upper gastrointestinal bleed. J Hepatol. 2015 Apr; 62(4):759-60. Morgan TR. PMID: 25543081.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. Binge alcohol promotes hypoxic liver injury through a CYP2E1-HIF-1α-dependent apoptosis pathway in mice and humans. Free Radic Biol Med. 2014 Dec; 77:183-94. Yun JW, Son MJ, Abdelmegeed MA, Banerjee A, Morgan TR, Yoo SH, Song BJ. PMID: 25236742; PMCID: PMC4304203.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    105. Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view. Hepatol Int. 2014 Sep 01; 8(2):447-51. Nguyen DL, Morgan T. PMID: 25525477; PMCID: PMC4267851.
      View in: PubMed   Mentions: 8     Fields:    
    106. The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp Mol Pathol. 2014 Oct; 97(2):305-13. Peng Y, French BA, Tillman B, Morgan TR, French SW. PMID: 25149528; PMCID: PMC4177273.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    107. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). Am J Cardiol. 2014 Oct 15; 114(8):1217-22. Fatemi O, Yuriditsky E, Tsioufis C, Tsachris D, Morgan T, Basile J, Bigger T, Cushman W, Goff D, Soliman EZ, Thomas A, Papademetriou V. PMID: 25159234; PMCID: PMC4291278.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansPHPublic Health
    108. TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies. Exp Mol Pathol. 2014 Oct; 97(2):234-40. Liu H, Li J, Tillman B, Morgan TR, French BA, French SW. PMID: 24997224; PMCID: PMC4177360.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    109. Update on recently approved treatments for hepatitis C. Curr Treat Options Gastroenterol. 2014 Jun; 12(2):211-28. Chao D, Botwin GJ, Morgan TR. PMID: 24648040.
      View in: PubMed   Mentions: 3  
    110. High rates of early treatment discontinuation in hepatitis C-infected US veterans. BMC Res Notes. 2014 Apr 24; 7:266. LaFleur J, Hoop R, Morgan T, DuVall SL, Pandya P, Korner E, Knippenberg K, Hayden C, Nelson RE. PMID: 24758162; PMCID: PMC4012175.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    111. Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy. Ann Pharmacother. 2014 Jul; 48(7):826-836. Nelson RE, Hoop R, Korner E, DuVall S, Hayden CL, Knippenberg K, Morgan T, Pandya P, Han J, LaFleur J. PMID: 24760408.
      View in: PubMed   Mentions: 1     Fields:    
    112. Bacterial infections in cirrhosis. Hepatol Int. 2014 Sep; 8 Suppl 2:467-74. Botwin GJ, Morgan TR. PMID: 26201326.
      View in: PubMed   Mentions: 6     Fields:    
    113. Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitor. Hepatology. 2014 Jun; 59(6):2423-4. Wang AS, Pfeiffer RM, Morgan TR, O'Brien TR. PMID: 24122888; PMCID: PMC3979526.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    114. Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat Genet. 2013 Nov; 45(11):1300-8. Cappello S, Gray MJ, Badouel C, Lange S, Einsiedler M, Srour M, Chitayat D, Hamdan FF, Jenkins ZA, Morgan T, Preitner N, Uster T, Thomas J, Shannon P, Morrison V, Di Donato N, Van Maldergem L, Neuhann T, Newbury-Ecob R, Swinkells M, Terhal P, Wilson LC, Zwijnenburg PJ, Sutherland-Smith AJ, Black MA, Markie D, Michaud JL, Simpson MA, Mansour S, McNeill H, Götz M, Robertson SP. PMID: 24056717.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansAnimalsCells
    115. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Nutr Res. 2013 Nov; 33(11):932-41. Kathirvel E, Morgan K, French SW, Morgan TR. PMID: 24176233.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    116. Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial. Gastroenterology. 2013 Nov; 145(5):1035-1044.e5. Poordad F, Lawitz E, Reddy KR, Afdhal NH, Hézode C, Zeuzem S, Lee SS, Calleja JL, Brown RS, Craxi A, Wedemeyer H, Nyberg L, Nelson DR, Rossaro L, Balart L, Morgan TR, Bacon BR, Flamm SL, Kowdley KV, Deng W, Koury KJ, Pedicone LD, Dutko FJ, Burroughs MH, Alves K, Wahl J, Brass CA, Albrecht JK, Sulkowski MS, Protocol 6086 Investigators. PMID: 23924660.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    117. Treatment of alcoholic hepatitis. Clin Liver Dis (Hoboken). 2013 Apr; 2(2):84-88. Morgan TR, Chao D, Botwin G. PMID: 30992831; PMCID: PMC6448618.
      View in: PubMed   Mentions:
    118. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013 Feb; 45(2):164-71. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. PMID: 23291588; PMCID: PMC3793390.
      View in: PubMed   Mentions: 473     Fields:    Translation:HumansCells
    119. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. J Psychosom Res. 2013 Jan; 74(1):57-63. Loftis JM, Patterson AL, Wilhelm CJ, McNett H, Morasco BJ, Huckans M, Morgan T, Saperstein S, Asghar A, Hauser P. PMID: 23272989; PMCID: PMC4408920.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    120. Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. Eur J Hum Genet. 2013 May; 21(5):494-502. Reinstein E, Frentz S, Morgan T, García-Miñaúr S, Leventer RJ, McGillivray G, Pariani M, van der Steen A, Pope M, Holder-Espinasse M, Scott R, Thompson EM, Robertson T, Coppin B, Siegel R, Bret Zurita M, Rodríguez JI, Morales C, Rodrigues Y, Arcas J, Saggar A, Horton M, Zackai E, Graham JM, Rimoin DL, Robertson SP. PMID: 23032111; PMCID: PMC3641385.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    121. Alcoholic liver disease - Hepatocellular carcinoma transformation. J Gastrointest Oncol. 2012 Sep; 3(3):174-81. French SW, Lee J, Zhong J, Morgan TR, Buslon V, Lungo W, French BA. PMID: 22943009; PMCID: PMC3418528.
      View in: PubMed   Mentions: 13  
    122. Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C. Am J Gastroenterol. 2012 Sep; 107(9):1388-98. Morishima C, Shiffman ML, Dienstag JL, Lindsay KL, Szabo G, Everson GT, Lok AS, Di Bisceglie AM, Ghany MG, Naishadham D, Morgan TR, Wright EC, HALT-C Trial Group. PMID: 22688849; PMCID: PMC3865099.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    123. Factors that predict response of patients with hepatitis C virus infection to boceprevir. Gastroenterology. 2012 Sep; 143(3):608-618.e5. Poordad F, Bronowicki JP, Gordon SC, Zeuzem S, Jacobson IM, Sulkowski MS, Poynard T, Morgan TR, Molony C, Pedicone LD, Sings HL, Burroughs MH, Sniukiene V, Boparai N, Goteti VS, Brass CA, Albrecht JK, Bacon BR, SPRINT-2 and RESPOND-2 Investigators. PMID: 22626609.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCellsCTClinical Trials
    124. Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am J Gastroenterol. 2012 May; 107(5):669-89; quiz 690. Yee HS, Chang MF, Pocha C, Lim J, Ross D, Morgan TR, Monto A, Department of Veterans Affairs Hepatitis C Resource Center Program, National Hepatitis C Program Office. PMID: 22525303.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    125. Host (avian) biting preference of southern California Culex mosquitoes (Diptera: Culicidae). J Med Entomol. 2012 May; 49(3):687-96. Lura T, Cummings R, Velten R, De Collibus K, Morgan T, Nguyen K, Gerry A. PMID: 22679878.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsPHPublic Health
    126. Ventricular catheter location and the clearance of intraventricular hemorrhage. Neurosurgery. 2012 May; 70(5):1258-63; discussion 1263-4. Jaffe J, Melnychuk E, Muschelli J, Ziai W, Morgan T, Hanley DF, Awad IA. PMID: 22067423; PMCID: PMC3719169.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    127. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012 May; 32(5):420-6. McFarland M, Davis K, Wallace J, Wan J, Cassidy R, Morgan T, Venugopal D. PMID: 22488512.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    128. Management of Adverse Events During the Treatment of Chronic Hepatitis C Infection. Clin Liver Dis (Hoboken). 2012 Apr; 1(2):54-57. Nguyen DL, Morgan TR. PMID: 25688295; PMCID: PMC4327830.
      View in: PubMed   Mentions: 3  
    129. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology. 2012 Apr; 55(4):1019-29. Everson GT, Shiffman ML, Hoefs JC, Morgan TR, Sterling RK, Wagner DA, Lauriski S, Curto TM, Stoddard A, Wright EC, HALT-C Trial Group. PMID: 22030902; PMCID: PMC3298578.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    130. Aging reduces left atrial performance during adrenergic stress in middle aged and older patients. Cardiol J. 2012; 19(1):45-52. Jeevanantham V, Chughtai H, Little WC, Morgan T, Kitzman DW, Hamilton CA, Hundley WG. PMID: 22298167; PMCID: PMC3767009.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    131. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C. Am J Gastroenterol. 2012 Jan; 107(1):64-74. Sterling RK, Wright EC, Morgan TR, Seeff LB, Hoefs JC, Di Bisceglie AM, Dienstag JL, Lok AS. PMID: 21931376; PMCID: PMC3903319.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    132. Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 2011 Aug; 54(2):434-42. Lok AS, Everhart JE, Di Bisceglie AM, Kim HY, Hussain M, Morgan TR, HALT-C Trial Group. PMID: 21374690; PMCID: PMC3134544.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    133. An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. PLoS One. 2011; 6(7):e20904. O'Brien TR, Everhart JE, Morgan TR, Lok AS, Chung RT, Shao Y, Shiffman ML, Dotrang M, Sninsky JJ, Bonkovsky HL, Pfeiffer RM, HALT-C Trial Group. PMID: 21760886; PMCID: PMC3132753.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    134. A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Hepatology. 2011 Aug; 54(2):396-405. Dienstag JL, Ghany MG, Morgan TR, Di Bisceglie AM, Bonkovsky HL, Kim HY, Seeff LB, Szabo G, Wright EC, Sterling RK, Everson GT, Lindsay KL, Lee WM, Lok AS, Morishima C, Stoddard AM, Everhart JE, HALT-C Trial Group. PMID: 21520194; PMCID: PMC3144992.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    135. Testing beneficial therapy in human cirrhosis using animal models of cirrhosis. Dig Dis Sci. 2011 Apr; 56(4):929-30. Hoefs JC, Morgan T, Ilagan BJ. PMID: 21365242; PMCID: PMC3059786.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    136. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon. Hepatology. 2011 Apr; 53(4):1100-8. Di Bisceglie AM, Stoddard AM, Dienstag JL, Shiffman ML, Seeff LB, Bonkovsky HL, Morishima C, Wright EC, Snow KK, Lee WM, Fontana RJ, Morgan TR, Ghany MG, HALT-C Trial Group. PMID: 21480316; PMCID: PMC3073857.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    137. Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study. Diabetes Care. 2011 May; 34(5):1219-24. Agarwal S, Morgan T, Herrington DM, Xu J, Cox AJ, Freedman BI, Carr JJ, Bowden DW. PMID: 21398528; PMCID: PMC3114476.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    138. Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology. 2011 May; 140(5):1490-500.e3. Lambrecht RW, Sterling RK, Naishadham D, Stoddard AM, Rogers T, Morishima C, Morgan TR, Bonkovsky HL, HALT-C Trial Group. PMID: 21335007; PMCID: PMC3081953.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    139. Chemoprevention of hepatocellular carcinoma in chronic hepatitis C. Recent Results Cancer Res. 2011; 188:85-99. Morgan TR. PMID: 21253791.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    140. IL28B-genotype testing now and in the era of direct-acting antiviral agents. Clin Gastroenterol Hepatol. 2011 Apr; 9(4):293-4. Morgan TR, O'Brien TR. PMID: 21185399; PMCID: PMC3065520.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    141. Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C. Am J Gastroenterol. 2011 May; 106(5):884-93. Fontana RJ, Sanyal AJ, Ghany MG, Bonkovsky HL, Morgan TR, Litman HJ, Reid AE, Lee WM, Naishadham D, HALT-C Trial Study Group. PMID: 21139575; PMCID: PMC3772514.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    142. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology. 2011 Mar; 140(3):840-9; quiz e12. Lok AS, Everhart JE, Wright EC, Di Bisceglie AM, Kim HY, Sterling RK, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Morgan TR, HALT-C Trial Group. PMID: 21129375; PMCID: PMC3057272.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCells
    143. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011 Feb; 60(2):255-60. Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ, Naveau S, Maddrey WC, Morgan TR. PMID: 20940288.
      View in: PubMed   Mentions: 150     Fields:    Translation:Humans
    144. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology. 2010 Sep; 52(3):833-44. Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, De Santo JL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Dienstag JL, Morishima C, Lindsay KL, Lok AS, HALT-C Trial Group. PMID: 20564351; PMCID: PMC2932862.
      View in: PubMed   Mentions: 157     Fields:    Translation:Humans
    145. Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine. Am J Physiol Gastrointest Liver Physiol. 2010 Nov; 299(5):G1068-77. Kathirvel E, Morgan K, Nandgiri G, Sandoval BC, Caudill MA, Bottiglieri T, French SW, Morgan TR. PMID: 20724529; PMCID: PMC2993168.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    146. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol. 2010 Jun; 25(6):1136-43. Kathirvel E, Chen P, Morgan K, French SW, Morgan TR. PMID: 20594230.
      View in: PubMed   Mentions: 45     Fields:    Translation:AnimalsCells
    147. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010 Oct; 8(10):877-83. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, Shiffman ML, Fontana RJ, Di Bisceglie AM, Bonkovsky HL, Dienstag JL, HALT–C Trial Group. PMID: 20362695; PMCID: PMC3771318.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCTClinical Trials
    148. Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology. 2010 Jun; 138(7):2321-31, 2331.e1-2. Fontana RJ, Sanyal AJ, Ghany MG, Lee WM, Reid AE, Naishadham D, Everson GT, Kahn JA, Di Bisceglie AM, Szabo G, Morgan TR, Everhart JE, HALT-C Trial Group. PMID: 20211180; PMCID: PMC2883673.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    149. Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial. Hepatology. 2009 Dec; 50(6):1738-49. Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, Wright EC, Brunt EM, Kleiner DE, Shiffman ML, Everson GT, Lindsay KL, Dienstag JL, Morishima C, HALT-C Trial Group. PMID: 19824074; PMCID: PMC3707633.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    150. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2010 Feb; 138(2):493-502. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL, HALT-C Trial Group. PMID: 19852963; PMCID: PMC2819612.
      View in: PubMed   Mentions: 241     Fields:    Translation:Humans
    151. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology. 2010 Jan; 138(1):136-46. Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL, HALT-C Trial Group. PMID: 19766643; PMCID: PMC2813393.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    152. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2009 Sep; 21(9):973-83. Kathirvel E, Morgan K, French SW, Morgan TR. PMID: 19307976.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    153. Alcoholic hepatitis. N Engl J Med. 2009 Jun 25; 360(26):2758-69. Lucey MR, Mathurin P, Morgan TR. PMID: 19553649.
      View in: PubMed   Mentions: 354     Fields:    Translation:Humans
    154. Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor. Cell Immunol. 2009; 259(2):117-27. Ge L, Zhang JG, Samathanam CA, Delgado C, Tarbiyat-Boldaji M, Dan Q, Hoa N, Nguyen TV, Alipanah R, Pham JT, Sanchez R, Wepsic HT, Morgan TR, Jadus MR. PMID: 19615673.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    155. Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2009 Jun; 49(6):1847-58. Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR, HALT-C Trial Group. PMID: 19434718; PMCID: PMC2692559.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    156. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 2009 Aug; 137(2):549-57. Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG, HALT-C Trial Group. PMID: 19445938; PMCID: PMC3148692.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    157. Re: Palliative sedation at home. J Palliat Care. 2009; 25(3):229; author reply 229. Morgan TR, Denholm MJ, Lawton S. PMID: 19824286.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    158. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol. 2009 Mar; 50(3):572-83. Butura A, Nilsson K, Morgan K, Morgan TR, French SW, Johansson I, Schuppe-Koistinen I, Ingelman-Sundberg M. PMID: 19157621.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimals
    159. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet. 2009 Jan; 41(1):95-100. Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-Miñaur S, Bohring A, Lacombe D, Stewart F, Fiskerstrand T, Bindoff L, Berland S, Adès LC, Tchan M, David A, Wilson LC, Hennekam RC, Donnai D, Mansour S, Cormier-Daire V, Robertson SP. PMID: 19079258.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    160. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008 Dec 04; 359(23):2429-41. Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL, HALT-C Trial Investigators. PMID: 19052125; PMCID: PMC2606037.
      View in: PubMed   Mentions: 156     Fields:    Translation:HumansCells
    161. Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C. Hepatology. 2008 Nov; 48(5):1412-9. Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM, HALT-C Trial Group. PMID: 18816437; PMCID: PMC2804270.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    162. Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin. Hepatology. 2008 Oct; 48(4):1033-43. Fried MW, Jensen DM, Rodriguez-Torres M, Nyberg LM, Di Bisceglie AM, Morgan TR, Pockros PJ, Lin A, Cupelli L, Duff F, Wang K, Nelson DR. PMID: 18697207.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    163. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009 Jan; 136(1):138-48. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD, HALT-C Trial Group. PMID: 18848939; PMCID: PMC3749922.
      View in: PubMed   Mentions: 228     Fields:    Translation:Humans
    164. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2008 Sep; 20(9):843-54. Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR. PMID: 18794597.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    165. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol. 2008 Aug; 42(7):827-34. Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR, VA HCV-001 Study Group. PMID: 18285716.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    166. DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol. 2008 Oct; 49(4):548-56. Morgan TR, Lambrecht RW, Bonkovsky HL, Chung RT, Naishadham D, Sterling RK, Fontana RJ, Lee WM, Ghany MG, Wright EC, O'Brien TR, HALT-C Trial Group. PMID: 18619701; PMCID: PMC3903339.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    167. Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C. Clin Gastroenterol Hepatol. 2008 Feb; 6(2):234-41. Lindsay KL, Morishima C, Wright EC, Dienstag JL, Shiffman ML, Everson GT, Lok AS, Bonkovsky HL, Lee WM, Morgan TR, Ghany MG, HALT-C Trial. PMID: 18237873.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    168. Commentary on 'designing phase II studies in cancer with time-to-event endpoints'. Clin Trials. 2008; 5(3):222-3; discussion 223-4. Case D, Morgan T. PMID: 18559410.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    169. Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response? Hepatology. 2007 Dec; 46(6):1671-4. Hoefs JC, Morgan TR. PMID: 18046713.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    170. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am J Cardiol. 2007 Jun 15; 99(12):1714-7. Terry JG, Carr JJ, Kouba EO, Davis DH, Menon L, Bender K, Chandler ET, Morgan T, Crouse JR. PMID: 17560880.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    171. Management of alcoholic hepatitis. Gastroenterol Hepatol (N Y). 2007 Feb; 3(2):97-9. Morgan TR. PMID: 21960817; PMCID: PMC3099359.
      View in: PubMed   Mentions: 5  
    172. Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):245-54. Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML, Everson GT, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Ghany MG, Morishima C, HALT-C Trial Group. PMID: 17296533.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    173. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci. 2007 Feb; 52(2):570-8. Hu KQ, Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, McCracken JD, Morgan T, Bräu N, Schmidt WN, Jeffers L, Wright TL, VA HCV-001 Study Group. PMID: 17226072.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    174. Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):124-9. Reddy KR, Shiffman ML, Morgan TR, Zeuzem S, Hadziyannis S, Hamzeh FM, Wright TL, Fried M. PMID: 17196435.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    175. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007 Mar; 46(3):420-31. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR, HALT-C Trial Group. PMID: 17196293; PMCID: PMC1995129.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    176. Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. Gastroenterology. 2007 Jan; 132(1):103-12. Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR. PMID: 17241864.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    177. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology. 2006 Aug; 44(2):360-7. Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR, HALT-C Trial Group. PMID: 16871570.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    178. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol. 2006 Jul; 101(7):1500-8. Lieber CS, Weiss DG, Morgan TR, Paronetto F. PMID: 16863553.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    179. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology. 2006 May; 43(5):954-60. Jensen DM, Morgan TR, Marcellin P, Pockros PJ, Reddy KR, Hadziyannis SJ, Ferenci P, Ackrill AM, Willems B. PMID: 16628671.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCells
    180. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2):47-52. Chen SL, Morgan TR. PMID: 16614742; PMCID: PMC1415841.
      View in: PubMed   Mentions: 259     Fields:    
    181. How useful and accurate is the new Glasgow alcoholic hepatitis scoring system? Nat Clin Pract Gastroenterol Hepatol. 2006 Jan; 3(1):14-5. Morgan TR. PMID: 16397604.
      View in: PubMed   Mentions: 1     Fields:    
    182. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol. 2005 Sep; 43(3):434-41. Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR, HALT-C Trial Group. PMID: 16136646.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCTClinical Trials
    183. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005 Aug; 42(2):282-92. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. PMID: 15986415.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    184. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol. 2005 Aug; 100(8):1772-9. Bini EJ, Bräu N, Currie S, Shen H, Anand BS, Hu KQ, Jeffers L, Ho SB, Johnson D, Schmidt WN, King P, Cheung R, Morgan TR, Awad J, Pedrosa M, Chang KM, Aytaman A, Simon F, Hagedorn C, Moseley R, Ahmad J, Mendenhall C, Waters B, Strader D, Sasaki AW, Rossi S, Wright TL. PMID: 16086714.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    185. Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology. 2005 Apr; 128(4):882-90. Morgan TR, Weiss DG, Nemchausky B, Schiff ER, Anand B, Simon F, Kidao J, Cecil B, Mendenhall CL, Nelson D, Lieber C, Pedrosa M, Jeffers L, Bloor J, Lumeng L, Marsano L, McClain C, Mishra G, Myers B, Leo M, Ponomarenko Y, Taylor D, Chedid A, French S, Kanel G, Murray N, Pinto P, Fong TL, Sather MR. PMID: 15825072.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    186. CYP2E1 inhibition enhances mallory body formation. Exp Mol Pathol. 2005 Jun; 78(3):207-11. Bardag-Gorce F, Wilson L, Nan L, Li J, French BA, Morgan TR, Morgan K, French SW. PMID: 15924872.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    187. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med. 2005 Mar 10; 6(1):3. Espeland MA, O'leary DH, Terry JG, Morgan T, Evans G, Mudra H. PMID: 15760471; PMCID: PMC555546.
      View in: PubMed   Mentions: 51  
    188. Alcohol and hepatitis C. Dig Dis. 2005; 23(3-4):285-96. Jamal MM, Saadi Z, Morgan TR. PMID: 16508293.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    189. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S87-96. Morgan TR, Mandayam S, Jamal MM. PMID: 15508108.
      View in: PubMed   Mentions: 209     Fields:    Translation:HumansCells
    190. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials. 2004 Oct; 25(5):472-92. Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE, HALT-C Trial Group. PMID: 15465617.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCTClinical Trials
    191. Caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): metabolic, physiologic, and atherosclerotic measures from a 4-year intervention trial. J Gerontol A Biol Sci Med Sci. 2004 Oct; 59(10):1007-14. Cefalu WT, Wang ZQ, Bell-Farrow AD, Collins J, Morgan T, Wagner JD. PMID: 15528768.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    192. Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004 Aug; 24(3):217-32. Mandayam S, Jamal MM, Morgan TR. PMID: 15349801.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    193. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology. 2004 Apr; 126(4):1015-23; discussion 947. Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky HL, Lee WM, Dienstag JL, Ghany MG, Goodman ZD, Everhart JE, Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. PMID: 15057741.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCTClinical Trials
    194. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004 Mar 02; 140(5):346-55. Hadziyannis SJ, Sette H, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM, PEGASYS International Study Group. PMID: 14996676.
      View in: PubMed   Mentions: 695     Fields:    Translation:HumansCellsCTClinical Trials
    195. Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat Genet. 2004 Apr; 36(4):405-10. Krakow D, Robertson SP, King LM, Morgan T, Sebald ET, Bertolotto C, Wachsmann-Hogiu S, Acuna D, Shapiro SS, Takafuta T, Aftimos S, Kim CA, Firth H, Steiner CE, Cormier-Daire V, Superti-Furga A, Bonafe L, Graham JM, Grix A, Bacino CA, Allanson J, Bialer MG, Lachman RS, Rimoin DL, Cohn DH. PMID: 14991055.
      View in: PubMed   Mentions: 100     Fields:    Translation:Cells
    196. Liver disease in alcohol and hepatitis C. Best Pract Res Clin Gastroenterol. 2003 Aug; 17(4):649-62. Jamal MM, Morgan TR. PMID: 12828960.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    197. The Arthritis, Diet and Activity Promotion Trial (ADAPT): design, rationale, and baseline results. Control Clin Trials. 2003 Aug; 24(4):462-80. Miller GD, Rejeski WJ, Williamson JD, Morgan T, Sevick MA, Loeser RF, Ettinger WH, Messier SP, ADAPT Investigators. PMID: 12865040.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    198. Hepatitis C and alcohol: fundamental and translational research directions. Alcohol Clin Exp Res. 2003 Apr; 27(4):726-31. Morgan TR, Brenner D, Everhart J, French SW, Fried MW, Gretch DR, Koziel MJ, McClain CJ, Peters MG, Weinman SA, Lucas DL. PMID: 12711937.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    199. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology. 2002 Jul; 36(1):122-34. Morgan K, French SW, Morgan TR. PMID: 12085356.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    200. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology. 2002 Mar; 35(3):688-93. McHutchison JG, Poynard T, Esteban-Mur R, Davis GL, Goodman ZD, Harvey J, Ling MH, Garaud JJ, Albrecht JK, Patel K, Dienstag JL, Morgan T, International Hepatitis Interventional Therapy Group. PMID: 11870385.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Timothy's Networks
    Concepts (646)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (41)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California